The social and financial cost of poor mental health of veterans is worth exploring all viable treatment pathways, including those involving MDMA and psilocybin. The remaining issue that needs to be addressed is the change of mindset of an entire industry of mental health professionals who will reach for psychoactive treatment as a last resort, after patients have exhausted all other options offered by pharmaceutical companies.